Category
11 plain-language articles on women's hormonal health — the physiology, the compounds, and what the evidence actually shows.
11 articles
Why your cycle gets worse during stressful seasons
During the easy seasons, your cycle is mostly cooperative. Mild PMS, predictable timing, manageable flow. Then a stressful stretch hits — a job change, a family situation, a sustained period of overwork — and the cycle starts behaving differently. PMS gets harder. The luteal phase becomes treacherous. Periods get heavier or longer, or skip altogether. Ovulation pain shows up. By the time things calm down, the cycle has rewritten itself.
Endometriosis and the inflammation cycle
Endometriosis is a structural disease. Ectopic endometrial-like tissue grows where it doesn't belong — on the ovaries, the peritoneum, the bowel, occasionally further afield — and it responds to the cyclical hormonal signals that drive the uterine lining. The lesions bleed, scar, and adhere. The pain is organic. The management is surgical and medical, and that has to be said clearly before anything else.
The four shifts of perimenopause — and which ones are driven by stress
Perimenopause is often described as a single transition, but the lived experience is more like four overlapping shifts happening at once — each with its own mechanism and its own timeline. Sleep changes, mood changes, cycle changes, hot flashes, energy collapse, weight redistribution, brain fog. They don't all share the same driver, which is why a single intervention rarely addresses all of them and why women describe perimenopause as feeling like several different transitions stacked on top of each other.
PMDD and the cortisol-progesterone connection
PMDD is not bad PMS. It's a distinct, diagnosable condition where the luteal phase doesn't just feel uncomfortable — it becomes destabilizing. Mood collapses. Rage arrives without warning. Suicidal ideation can show up in women who feel completely well three days later, after the period starts. The pattern repeats month after month, and the recognition that the timeline is hormonal does nothing to soften the experience of living through it.
Uterine fibroids and the stress factor
Fibroids are extraordinarily common — by age 50, the majority of women have at least one — and they range from incidental findings on a routine ultrasound to lesions that drive heavy bleeding, anemia, and pressure symptoms that meaningfully interfere with daily life. The conversation about fibroids and stress isn't whether stress causes them; it's whether the hormonal and inflammatory environment that influences their growth velocity is partly shaped upstream. The honest answer is yes — within limits worth being precise about.
Curcumin and the NF-kB switch in endometriosis
Inside an endometriotic stromal cell, a great deal of bad behavior funnels through a single switch. Inflammatory signals arrive, oxidative stress builds, prostaglandins accumulate — and all of it converges on a transcription factor called NF-kB, which, once released, walks into the nucleus and turns on the genes that keep the lesion inflamed, fed, and invasive. Now picture a yellow pigment from a kitchen spice slipping into that same cell and jamming the switch one step upstream. That is, in essence, what curcumin does, and it is why a compound most people associate with curry has earned a place in the serious conversation about endometriosis biology.
N-acetylcysteine for endometriosis — the strongest non-hormonal signal
In a small Italian clinic, a group of women with ovarian endometriomas were given a simple, decades-old over-the-counter compound and asked to come back for repeat imaging. When they did, something quietly unusual showed up on the scans: a number of the cysts had not grown the way endometriomas usually do between visits, and several had shrunk. In the women who took nothing, the cysts continued along their expected trajectory. The compound was not a hormone. It was not a surgical instrument. It was N-acetylcysteine — a cysteine donor that pharmacists have stocked for years as a mucolytic and as the antidote for acetaminophen overdose. That a substance this unglamorous produced a measurable, lesion-level change in a disease defined by its stubbornness is the reason it deserves a careful look.
GLP-1 for PMOS: The 2026 Evidence, and Who Actually Benefits
The internet has already decided that GLP-1 drugs fix polyendocrine metabolic ovarian syndrome (PMOS, formerly PCOS). The literature is more disciplined, and more useful. Three things happened in 2026 that make this worth a careful read: the condition was formally renamed to center its metabolic core, several rigorous meta-analyses landed, and the first proper head-to-head combination trials reported. Put together, they let us answer the only question that matters for an individual woman: not "do these drugs work," but "would they work for me, and at what cost."
The Insulin Resistance Engine: Why PMOS Is a Metabolic Condition First
When polycystic ovary syndrome was renamed polyendocrine metabolic ovarian syndrome (PMOS) in 2026, the word "metabolic" moved into the name for a reason. For most women who carry this diagnosis, the engine running underneath the symptoms is not the ovary. It is insulin resistance. Understand that one mechanism and almost everything else about the condition, the irregular cycles, the stubborn weight, the acne and hair changes, the long-term risk of diabetes and heart disease, starts to make sense as a single connected system rather than a scattered list of problems.
Coming off birth control — the cycle that doesn't quite return
You stopped the pill on a Sunday. Your doctor said your cycle would return in a few weeks. Maybe a month. By month three, you had a period — one period — and then silence for another eight weeks. The acne that started showing up on your jaw looked exactly like what you had at seventeen. Your skin was oily in a way it hadn't been in years. Your hair felt different. You felt different, in a way that's hard to articulate but impossible to ignore — more reactive, more raw, cycling through moods in ways you didn't remember doing before. The pill, you realized, had been doing more than preventing pregnancy.
Vitamin D and omega-3 in endometriosis — the quiet anti-inflammatory levers
Pull the lab panel of a roomful of women with endometriosis and a pattern keeps surfacing: the 25-hydroxyvitamin D values run low, and the lowest of them cluster in the women whose disease is most advanced. It is the kind of association that is easy to dismiss as background noise — vitamin D is low in a great many conditions — until you look at what the vitamin actually does inside the tissues that endometriosis colonizes. Then the correlation starts to look less like coincidence and more like a clue. Vitamin D and the omega-3 fatty acids in fish oil are the two quietest levers in the endometriosis conversation, unglamorous next to surgery and hormones, and both turn out to act on the disease's biology in ways that are well understood at the molecular level even where the clinical proof is still arriving.